The risk of atherosclerosis in patients with chronic kidney disease
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic kidney disease (CKD) is becoming a serious health problem; the number of people with impaired renal function is rapidly rising, especially in industrialized countries. A major complication of CKD is cardiovascular disease. Accelerated atherosclerosis has been observed in early stages of renal dysfunction. The purpose of this study was to examine the relationship between the degree of renal insufficiency and both the prevalence and intensity of coronary artery disease (assessed on the basis of number of vessels with stenosis). METHODS: 446 individuals with both serum creatinine >120 μmol/l (men) or >96 μmol/l (women) and acute coronary syndrome were included in the study. All patients included in this analysis underwent urgent coronarography. Data concerning glomerular filtration rate (GFR), number of vessels with stenosis, hypertension, lipid disorders, creatinine concentration, C-reactive protein, glucose and lipid profile were analyzed. RESULTS: This study confirmed that moderate to severe renal impairment is associated with accelerated atherosclerosis. Moreover, patients with GFR values below 60 ml/min/1.73 m(2) are predisposed to accelerated, multivessel cardiovascular disease. CONCLUSIONS: GFR seems to be an independent risk factor for multivessel cardiovascular disease. Due to the fact that patients with renal dysfunction are at high risk of cardiovascular events, they should obtain optimal treatment resulting not only in kidney protection but also in the elimination of cardiovascular risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the adult population, a decreasing GFR is associated with an increased CVD risk, independent of other CV risk factors. 388-391”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [388]
In the citing paper
“Patients with stage 3-5 CKD have to be considered at high or very high CV risk.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [388]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615 · cited 1×
“Estimated glomerular filtration rate (eGFR) was calculated for all subjects using the MDRD equation [11].”
MethodSarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768 · cited 2×
“Such disturbances may lead not only to the progression of kidney disease, but also to accelerated atherosclerosis, calcification of lesions and intimamedia thickening [9, 25].”
BackgroundDe Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f0580f · Cited by 1,837
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000102971.85504.7c · Cited by 1,144
Wada, K., Tanaka, K., & Nakashima, K. (2011) · PubMed · Cited by 1,132
Levey, A., Beto, J., Coronado, B., Eknoyan, G., Foley, R., Kasiske, B., Klag, M., Mailloux, L., Manske, C., Meyer, K., et al. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70145-3 · Cited by 946 · cited 1×
“A slight decline in glomerular filtration rate in the second stage of chronic renal disease results in two- to threefold higher risk of CAD; in dialyzed patients, this risk is increased from 10 to 100 times in comparison with the general population [3].”
BackgroundChronic kidney disease as cause of cardiovascular morbidity and mortality
Vanholder, R., Massy, Z., Argiles, A., Spasovski, G., Verbeke, F., & Lameire, N. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh813 · Cited by 613
Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination
Wright, R. S., Reeder, G. S., Herzog, C. A., Albright, R. C., Williams, B. A., Dvorak, D. L., Miller, W. L., Murphy, J. G., Kopecky, S. L., & Jaffe, A. S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00007 · Cited by 595 · cited 2×
“[20] demonstrated that the mortality of patients receiving dialysis reaches 60 % in the first year after a first MI, while in-hospital mortality after an MI is 2 % in subjects with normal renal function, 6 % with mild CKD, 14 % with moderate CKD, 21 % with severe CKD and 30 % in dialysis patients [20].”
BackgroundChronic renal diseases as a public health problem: Epidemiology, social, and economic implications
Schieppati, A., & Remuzzi, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09801.x · Cited by 447 · cited 1×
“Chronic kidney disease (CKD) is becoming a serious health problem; the number of people with impaired renal function is rapidly rising, especially in industrialized countries [1].”
BackgroundCardiovascular mortality in children and young adults with end-stage kidney disease
Parekh, R. S., Carroll, C. E., Wolfe, R. A., & Port, F. K. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.125910 · Cited by 445
Ohtake, T., Kobayashi, S., Moriya, H., Negishi, K., Okamoto, K., Maesato, K., & Saito, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090765 · Cited by 283
Hyperlipidemia in patients with chronic renal disease
Kasiske, B. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820472 · Cited by 281 · cited 1×
“Numerous studies have revealed that in CKD dialyzed patients, the relation between cholesterol level and mortality is frequently reversed, meaning that low levels of TCH are associated with higher cardiovascular mortality [8].”
BackgroundCharytan, D., & Kuntz, R. E. (2006) · Kidney International · doi:10.1038/sj.ki.5001934 · Cited by 271 · cited 1×
“Among 86 studies regarding various methods of CAD treatment published between 1998 and 2005, as many as 80 % of them excluded patients with end-stage renal disease and 75 % excluded patients in earlier CKD stages [27].”
Method2007 ESH–ESC practice guidelines for the management of arterial hypertension
(2008) · Manual of Hypertension of The European Society of Hypertension · doi:10.3109/9780203091722-57 · Cited by 236
McCullough, P. A., Sandberg, K. R., Borzak, S., Hudson, M. P., Garg, M., & Manley, H. J. (2002) · American Heart Journal · doi:10.1067/mhj.2002.125513 · Cited by 204 · cited 1×
“Patients with CKD have also much greater mortality from myocardial infarctions (MIs) [20, 21].”
BackgroundGibson, C., Dumaine, R. L., Gelfand, E. V., Murphy, S. A., Morrow, D. A., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., & Braunwald, E. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.08.016 · Cited by 152 · cited 2×
“elevation (NSTEMI ACS), a decrease in renal function is linked to a higher percentage of 3-vessel disease and that eGFR is independently associated with 30-day and 6-month mortality [29].”
BackgroundMetabolic syndrome and renal disease
Gluba-Brzózka, A., Mikhailidis, D. P., Lip, G. Y. H., Hannam, S., Rysz, J., & Banach, M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.013 · Cited by 120 · cited 1×
“Such disturbances may lead not only to the progression of kidney disease, but also to accelerated atherosclerosis, calcification of lesions and intimamedia thickening [9, 25].”
BackgroundSelf-citationRenal Function and Risk of Myocardial Infarction in an Elderly Population: The Rotterdam Study
Brugts, J. J., Knetsch, A. M., Mattace-Raso, F. U. S., Hofman, A., & Witteman, J. C. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2659 · Cited by 88
Atherosclerosis and Vascular Calcification in Chronic Renal Failure
Campean, V., Neureiter, D., Varga, I., Runk, F., Reiman, A., Garlichs, C., Achenbach, S., Nonnast-Daniel, B., & Amann, K. (2005) · Kidney and Blood Pressure Research · doi:10.1159/000090182 · Cited by 83
Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., Backer, G. D., Ebrahim, S., Gjelsvik, B., et al. (2008) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2008-4-3-111-128 · Cited by 72
State of the art papers Lipids, blood pressure, kidney – what was new in 2011?
Barylski, M., Małyszko, J., Rysz, J., Myśliwiec, M., & Banach, M. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.26620 · Cited by 61 · cited 1×
“Also, dyslipidemia is highly prevalent among patients with CKD [6, 7].”
BackgroundSelf-citationFp, B., & Selwood, N. H. (1992) · PubMed · Cited by 57
Angiographic progression of coronary artery disease in patients with end‐stage renal disease
Gradaus, F., Ivens, K., Peters, A., Heering, P., Schoebel, F. C., Grabensee, B., & Strauer, B. E. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.6.1198 · Cited by 56 · cited 1×
“[24] reported an association between renal disease and the number of atherosclerotic lesions.”
BackgroundCurrent problems in hypertension and nephrology
Banach, M., & Rysz, J. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.522569 · Cited by 33 · cited 1×
“Hypertension (HA) is one of the main causes of chronic kidney disease and is present in 70 % of CKD patients and in 80–90 % of dialyzed patients [4, 5].”
BackgroundSelf-citationKhalique, O. K., Aronow, W. S., Ahn, C. W., Mazar, M., Schair, B., Shao, J. H., & Channamsetty, V. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.038 · Cited by 32 · cited 3×
“[26] observed high prevalence of classical CAD risk factors in patients with CKD.”
BackgroundInfluentialMałyszko, J., Bachórzewska-Gajewska, H., Małyszko, J. S., Iaina-Levin, N., Kobus, G., & Dobrzycki, S. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.24136 · Cited by 30 · cited 1×
“However, recent studies have suggested that in patients with chronic kidney disease, the increased occurrence of atherosclerosis is also associated with novel risk factors such as chronic inflammatory state, calcium–phosphate metabolism disturbances, oxidative stress, malnutrition, anemia, fluid overload, fluctuation…”
BackgroundStatins in patients with chronic kidney disease: why, who and when?
Gluba-Brzózka, A., Rysz, J., & Banach, M. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.512419 · Cited by 30 · cited 1×
“Also, dyslipidemia is highly prevalent among patients with CKD [6, 7].”
BackgroundSelf-citationAcute coronary syndromes in patients with chronic kidney disease
Franczyk-Skóra, B., Gluba, A., Banach, M., Rozentryt, P., Poloński, L., & Rysz, J. (2013) · Current Vascular Pharmacology · doi:10.2174/1570161111311050013 · Cited by 23
Self-citationFácila, L., Núñez, J. E., Bodí, V., Sanchís, J. M., Bertomeu‐González, V., Consuegra, L., Pellicer, M., Ferrero, Á., Sanjuán, R., & Llácer, Á. (2006) · Revista Española de Cardiología · doi:10.1157/13086077 · Cited by 16
The heart in uremia: Role of hypertension, hypotension, and sleep apnea
Santo, N. G. D., Círillo, M., Perna, A. F., Santo, L. S. D., Anastasio, P., Pollastro, M. R., Santo, R. M. D., Iorio, L., Cotrufo, M. F., & Rossi, F. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27395 · Cited by 13 · cited 1×
“Hypertension (HA) is one of the main causes of chronic kidney disease and is present in 70 % of CKD patients and in 80–90 % of dialyzed patients [4, 5].”
BackgroundPrognostic Value of Serum Creatinine in Non-ST-Elevation Acute Coronary Syndrome
Fácila, L., Núñez, J. E., Bodí, V., Sanchís, J. M., Bertomeu‐González, V., Consuegra, L., Pellicer, M., Ferrero, Á., Sanjuán, R., & Llácer, Á. (2006) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)70023-8 · Cited by 13 · cited 1×
“However, according to a study of creatinine level at admission, it is one of the most important covariates in early prognostic stratification of patients with non-STelevation acute coronary syndrome [30].”
BackgroundWorld Kidney Day 2011:Protect Your Kidneys, Save Your Heart
William, W., Couser, Miguel, M. D., & Riella (2011) · Chinese Journal of Nephrology,Dialysis & Transplantation · Cited by 11
Editorial World Kidney Day 2011: Protect your kidneys, save your heart
Couser, W. G., & RIELLA, M. C. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.20596 · Cited by 9
[ENZYMES IN THE DIAGNOSIS OF MYOCARDIAL INFARCTION].
Dybicki, J., Bc, B., WOODFIN, M. C., Js, H., JOHNSTON, H., Co, B., Stephenson, S. E., & Meneely, G. R. (1965) · PubMed · Cited by 3
Research works printed but not linked: 1
- Pietrasik A Starczewska M Główczyńska R Secondary prevention of myocardial infarction in primary health care in Poland—selected results of the POLKARD-SPOK Kardiol Pol 2006 8 Suppl 3 1 12
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
“In the adult population, a decreasing GFR is associated with an increased CVD risk, independent of other CV risk factors.(388) –391 The CV mortality in patients with stage 3 and stage 4 CKD is two-fold and three-fold higher, respectively, when compared with patients with normal renal function.”
BackgroundSerum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Stubbs, J. R., House, J. A., Ocque, A. J., Zhang, S., Johnson, C., Kimber, C., Schmidt, K., Gupta, A., Wetmore, J. B., Nolin, T. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111063 · Cited by 450
Metadata
- Authors
- Olechnowicz-Tietz, S., Gluba, A., Paradowska, A., Banach, M., & Rysz, J.
- Affiliations
- Copernicus Memorial Hospital (PL)
- Medical University of Lodz (PL)
- Venue
- International Urology and Nephrology
- Published
- 2013-03-13
- Volume
- 45
- Issue
- 6
- Pages
- 1605-1612
- ISSN
- 0301-1623 (ISSN-L)
- 1573-2584
- PMC
- PMC3844144
- OpenAlex
- W2052237041
- Cited by
- 105
- References
- 39
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 5 · 2022: 2 · 2021: 9 · 2020: 12 · 2019: 15 · 2018: 14 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 7 · 2013: 6
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- International Urology and Nephrology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease, atherosclerosis, coronary artery disease, glomerular filtration rate, renal dysfunction, acute coronary syndrome, cardiovascular risk factors, C-reactive protein, lipid profile, hypertension
- MeSH terms
- Aged, C-Reactive Protein, Coronary Vessels, Creatinine, Female, Glomerular Filtration Rate, Humans, Male, Middle Aged, Radiography, Retrospective Studies, ROC Curve, Severity of Illness Index, Prevalence, Risk Assessment, Atherosclerosis, Renal Insufficiency, Chronic, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.